Somenek + PittmanMD in Washington, DC is excited to be the first Plastic Surgery practice in the area to offer Avéli™ for a meaningful reduction in cellulite dimples.
Avéli™ Cellulite Reduction Procedure
Dr. Pittman discusses Aveli on ABC7 – Good Morning Washington
Cellulite is a depression of any shape or size with defined edges seen on the surface of the skin, typically on the buttocks or thighs. A major underlying cause of cellulite are the fibrous bands that tether your skin to the structures below. These bands are called septa. Some septa are good (and you want them as connective tethers), but others stiffen or shrink over time and lead to the dimples we see on the surface and call cellulite.
It’s important to distinguish cellulite from other concerns like laxity or localized fat, which Dr. Pittman can talk you through during a consultation in our office. You should also know that cellulite is not your fault (genetics and hormones play a role), and you are not alone – up to 90% of women have it!
What is Avéli™?
Avéli™ is a no-nonsense approach to treating cellulite dimples based on a deep understanding of women’s anatomy. While many treatments approach cellulite blindly from the outside-in, Avéli™ identifies and releases the primary structural cause of cellulite from the inside-out in a single minimally-invasive procedure.
How does Avéli™ work?
Avéli™ works for a range of women across the cellulite severity spectrum. The procedure is performed by Dr. Pittman using a handheld device to manually target and release the complicated web of septa bands causing cellulite dimples.
Avéli™ addresses the primary structural cause of cellulite in 3 steps:
- Dr. Pittman guides the Avéli™ device under the skin directly to the targeted dimples.
- After the culprit septa bands causing a dimple are identified, those septa are precisely released.
- Dr. Pittman can confirm their release in real-time delivering visibly smoother skin.
More Common Questions
Q: How do I know if Avéli™ is right for me?
A: If you are a patient looking for a visible reduction in cellulite dimples from a single, minimally invasive procedure, Avéli™ could be for you! Schedule a consultation with Dr. Pittman to determine if you are a candidate.
Q: Does Avéli™ only treat cellulite dimples?
A: Avéli™ treats the septa bands causing cellulite dimples. It is not a procedure that addresses other concerns often seen alongside cellulite, such as laxity (loose skin) or localized pockets of fat. Often times, Avéli™ can be combined with liposuction to treat unwanted areas of fat in the same session.
Q: Will I need multiple sessions?
A: Nope! During a single procedure, Dr. Pittman can fully treat the targeted cellulite dimples on both your buttocks and thighs.
Q: How long does the procedure take?
A: A typical procedure will take around an hour, including local anesthesia and the procedure itself. Exact timing will vary depending on the personalized procedure plan from Dr. Pittman.
Q: Is there any downtime after the procedure?
A: Little to none. In the clinical study, most patients returned to normal activities within 24-48 hours.
Q: Are there any side effects?
A: The most common side effects reported were mild pain within the first 24 hours and bruising and tenderness to the touch which typically resolved within 30 days. Small areas of firmness, usually not visible or painful, typically resolved in a couple of months.
Q: How quickly will I see improvement in my cellulite?
A: Avéli™ results should be visible once swelling and bruising subsides. By one-month post-procedure you should start to see the effects of the procedure.
Q: Can I work out or exercise after the procedure?
A: It is recommended to avoid any strenuous activities or workouts in the first few days/weeks after the procedure to allow the area to heal. We will provide you with complete post-procedure expectations and recommendations.
Q: How long will the results last?
A: Patients in the clinical study demonstrated a reduction in the appearance of their cellulite when assessed at three months after the procedure. Patients in the study will continue to be followed through 12 months post-procedure.